Feb 7 (Reuters) - Auxly Cannabis Group Inc XLY.V :
* AUXLY ANNOUNCES TERMINATION OF FSD PHARMA JOINT VENTURE
* AUXLY ANNOUNCES TERMINATION OF FSD PHARMA JOINT VENTURE
* AUXLY CANNABIS GROUP - CO IDENTIFIED CONTRACTUAL BREACHES
RELATING TO FSD PHARMA'S MANAGEMENT AND STAFFING OBLIGATIONS OF
JV FACILITY
* AUXLY CANNABIS GROUP - ON JAN 17, PROVIDED NOTICE TO FSD
PHARMA
OF SUCH BREACHES IN HOPES THAT FSD PHARMA WOULD WORK WITH
COMPANY TOWARD A RESOLUTION
* AUXLY CANNABIS GROUP - TERMINATION OF JOINT VENTURE
ARRANGEMENT
WITH FSD PHARMA DOES NOT MATERIALLY IMPACT CO'S STRATEGY NOR
SUPPLY PIPELINE
* AUXLY CANNABIS GROUP INC - RESERVES ALL OF ITS RIGHTS
UNDER
AGREEMENT WITH FSD PHARMA
* AUXLY CANNABIS GROUP- WILL EXPLORE STRATEGIC ALTERNATIVES
FOR
ABOUT $50 MILLION IN CAPITAL THAT WAS EARMARKED FOR FSD PHARMA,
NOW AVAILABLE FOR DEPLOYMENT
* AUXLY CANNABIS GROUP INC - CO ASLO IDENTIFIED "SIGNIFICANT
CONCERNS" REGARDING CERTAIN ASPECTS OF JV'S BUILDINGS'
INFRASTRUCTURE
* AUXLY CANNABIS GROUP INC - FSD PHARMA FAILED TO REMEDY ITS
BREACHES AND INSTEAD PURPORTED TO TERMINATE AGREEMENT EFFECTIVE
FEBRUARY 6, 2019
Source text for Eikon: ID:nGNX5CLLkS
Further company coverage: XLY.V
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com))